- Home
- UTG vs ACLX Comparison
UTG vs ACLX Comparison
Compare UTG & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTG
- ACLX
- Stock Information
- Founded
- UTG 2003
- ACLX 2015
- Country
- UTG United States
- ACLX United States
- Employees
- UTG N/A
- ACLX N/A
- Industry
- UTG Investment Managers
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- UTG Finance
- ACLX Health Care
- Exchange
- UTG Nasdaq
- ACLX Nasdaq
- Market Cap
- UTG 2.8B
- ACLX 3.3B
- IPO Year
- UTG N/A
- ACLX 2022
- Fundamental
- Price
- UTG $32.50
- ACLX $65.60
- Analyst Decision
- UTG
- ACLX Strong Buy
- Analyst Count
- UTG 0
- ACLX 13
- Target Price
- UTG N/A
- ACLX $110.82
- AVG Volume (30 Days)
- UTG 317.8K
- ACLX 589.2K
- Earning Date
- UTG 01-01-0001
- ACLX 05-08-2025
- Dividend Yield
- UTG 7.28%
- ACLX N/A
- EPS Growth
- UTG N/A
- ACLX N/A
- EPS
- UTG 9.86
- ACLX N/A
- Revenue
- UTG $96,107,593.00
- ACLX $107,936,000.00
- Revenue This Year
- UTG N/A
- ACLX N/A
- Revenue Next Year
- UTG N/A
- ACLX $103.84
- P/E Ratio
- UTG $3.20
- ACLX N/A
- Revenue Growth
- UTG 8.35
- ACLX N/A
- 52 Week Low
- UTG $25.26
- ACLX $47.88
- 52 Week High
- UTG $35.29
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- UTG 48.98
- ACLX 42.53
- Support Level
- UTG $32.31
- ACLX $68.56
- Resistance Level
- UTG $33.02
- ACLX $72.68
- Average True Range (ATR)
- UTG 0.44
- ACLX 3.13
- MACD
- UTG 0.06
- ACLX -0.57
- Stochastic Oscillator
- UTG 58.66
- ACLX 35.23
About UTG Reaves Utility Income Fund of Beneficial Interest
Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.